Fitbit reported its fourth quarter and full year earnings yesterday. Fourth quarter earnings continues to post a loss, with a reported $571 million in revenues and a net loss of $46 million, as did its full year report, in which the company reported a total revenue of $1.6 b
from MobiHealthNews http://ift.tt/2oFQCUt
March 01, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Benchling gets $14.5M to build collaboration tools for biotechs, pharmasBenchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.5 million in series B funding. Benchmark led the round, with additional partici… Read More
Valencell's partnership with earphone manufacturer leads to $10.5M raiseBiometric sensor technology company Valencell announced this week that it has raised $10.5 million in Series E, bringing the company’s total funding to $35 million. The new backing primarily comes as the result of a strategic… Read More
Digital brain biomarker startup raises $15M in Series B fundingMindstrong Health, a company that uses phone activity to measure mental health and behavior, has just closed a $15 million Series B funding round. This newest backing brings the startups total financing to $29 million, … Read More
In-Depth: Consumer genomics furthers healthcare foothold but privacy, resource concerns persistIn the last few years consumer genomics has grown in both its offerings and legitimacy. The industry that was once best known for telling clients if they were Italian or Hungarian is now securing its foothold within the healt… Read More
FDA approves wearable device for opioid withdrawal symptom treatment deviceDyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withd… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment